baber/WOPTO huggingface dataset:
Patent NZ-278185-A (NZ)
Title: Network manager for cable television system headend components and set top terminals in a television delivery system which coordinates the reception of programming and control signals at a headend
Inventor: HENDRICKS JOHN S
IPC: H04N5/00
Filed: 1994-12-02
Abstract: A novel network manager for use with a cable television system headend capable of monitoring and managing headend components and set top terminals in a television delivery system. The invention relates to methods and apparatus that manage and coordinate the reception of requested video on demand programs. The invention manages and coordinates the storage of the requested video on demand programs for intelligent selection and distribution to set top terminals. <IMAGE>
Patent NZ-298989-A (NZ)
Title: Non-aqueous coating and ink compositions containing a modified carbon(black) product having an attached aromatic group
Inventor: BELMONT JAMES A
IPC: C09D7/62
Filed: 1995-12-14
Abstract: escribed is a non-aqueous coating or ink composition having incorporated therein a modified carbon product comprising carbon having attached a substituted or unsubstituted aromatic group, wherein the aromatic group is directly attached to the carbon.  Also described is a modified carbon product comprising carbon and an attached organic group having a) an aromatic group and b) at least one group of the formula SO2NR2 or SO2NR(COR) wherein R is independently hydrogen, a C1-C20 substituted or unsubstituted alkyl, a C3-C20 substituted or unsubstituted alkenyl, (C2-C4 alkyleneoxy)xR' or a substituted or unsubstituted aryl; R' is hydrogen, a C1-C20 substituted or unsubstituted alkyl, a C3-C20 substituted or unsubstituted alkenyl, C1-C20 substituted or unsubstituted alkanoyl or substituted or unsubstituted aroyl; and x is from 1 to 40.
Patent NZ-329815-A (NZ)
Title: Computer-based method of operating a loyalty system for vendors and purchasers of goods and services
Inventor: COLLINS PAUL MAXWELL
IPC: G06F19/00
Filed: 1998-02-20
Abstract: A computer based method of operating a loyalty system for vendors and purchasers of goods or services comprises; a) creating a database of vendor and purchaser subscribers to the system; b) arranging contracts with financial organizations such as investment or insurance companies; c) receiving transaction data relating to electronic payments made by the purchasers to the vendors and d) periodically arranging payments to the financial organizations as required on behalf of the purchasers to satisfy the contract for benefits.
Patent NZ-334007-A (NZ)
Title: Needleless syringe, flow from gas capsule initially towards rear of syringe
Inventor: SURMAN DAVID
IPC: A61M5/20
Filed: 1999-02-02
Abstract: A needleless syringe 2 includes a capsule 8 which contains gas under pressure for propelling a medicament contained at 10 out of nozzle 4 and through the skin of a patient.  The gas capsule has a frangible section 16, which releases the gas from the capsule when broken.  The gas initially is ejected from the capsule in a direction towards the rear of the syringe, and away from the nozzle 4.  The gas then flows around the sides of the capsule, through holes in partition 18 to propel the medicament from nozzle 4.  The frangible section may be broken by pushing a button 30.  A pin 36 prevents the button from being accidentally pressed.
Patent NZ-336395-A (NZ)
Title: Highly absorbent composite compositions, absorbent sheets provided with the compositions, and process for producing the same
Inventor: SUZUKI MIGAKU
IPC: A61F13/15
Filed: 1997-12-15
Abstract: Absorbent compositions containing as the major components, fine hydratable microfibril fibers obtained from cellulose or derivatives thereof and a solid capable of swelling with water, wherein at least part of the surface of the solid is coated with the fine microfibril fibers. The solid capable of swelling with water is exemplified by particulate polymer absorbents to which short fibers have been added as the third component. These composite absorbents may be located on supporting sheets made of, for example, a non-woven fabric to give composite absorbent sheets applicable to various absorbent products including diapers for infants and adults.
Patent NZ-500273-A (NZ)
Title: Gadolinium (Gd) polymer MRI contrast agent responsive to environmental changes
Inventor: MIKAWA MASAHITO
IPC: A61K49/12
Filed: 1998-03-16
Abstract: A contrast media composition particularly useful for MRI contains complexes of gadolinium (Gd)-base contrast media with polymers.  The polymers have the property to undergo phase transition due to changes in pH value, light or temperature induced in the body by physical stimulation from outside the body to develop different water solubility. Since the polymers responding to minor environmental changes are bonded to the Gd-base MRI contrast media, the performance of the contrast media can be exerted exclusively at the target sites, thus enabling on-off switching of the performance of MRI contrast media. Therefore, the contrast media are highly specific, meaning that the contrast is provided not at the sites where no contrast is needed but exclusively at the target tumors or specific sites, thus ensuring highly specific MRI diagnosis.
Patent NZ-500276-A (NZ)
Title: Process for determining a tissue composition characteristic of an animal by infrared thermographic image
Inventor: SCHAEFER ALLAN L
IPC: G01N25/72
Filed: 1998-03-17
Abstract: A process for determining a tissue composition characteristic of a live animal or carcass involves the steps of: (a) obtaining either or both of at least one infrared thermographic image of the animal while it is alive, taken from at least one view, or at least one image of the carcass of the animal after slaughter, taken from at least one view, each thermographic image being capable of being represented as an array of pixels providing temperature data representative of temperature information at the corresponding part of the image; (b) calculating the value of at least one statistical measure of the temperature data for each thermographic image; (c) providing a predictive model wherein the tissue composition characteristic is included as an output variable, and the statistical measures of temperature data for each thermographic image are included as input variables; and (d) solving the predictive model to provide the value of the tissue composition characteristic. Tissue composition characteristics of interest include lean body mass, cuttability, degree of marbling, percent carcass yield, lean yield, rib eye area, loin eye area, subcutaneous fat thickness and grade classification. An apparatus for performing the processes of the invention includes: (a) image acquisition means for obtaining the infrared thermographic images; (b) computing and storage means for storing each image as an array of pixels, calculating the value of statistical measures of the temperature data for each thermographic image, and providing and solving the predictive model; and (c) output means for providing an output of the value of the tissue composition characteristic.
Patent NZ-501422-A (NZ)
Title: Intramuscular stimulation system comprising a plurality of implantable electrodes in combination with a portable device equipped with a memorised set of movements for eliciting a series of muscle responses to prevent muscle atrophy
Inventor: FANG ZI-PING
IPC: A61N1/36
Filed: 1999-05-10
Abstract: A portable intramuscular stimulation system comprises a plurality of intramuscular stimulation electrodes for implantation directly into selected muscles of an individual, each electrode includes a deinsulated percutaneous lead, a housing sized and configured to be carried by the individual, a microprocessor-based stimulation pulse generator carried by the housing for generating select electrical stimulation pulse trains. The pulse train generator includes a battery carried by the housing to power the pulse train generator, a plurality of electrical stimulation pulse train output channels carried by the housing adapted to be connected to the plurality of percutaneous leads, an input device carried by the housing to select stimulation pulse train parameters for each of the stimulation pulse train output channels. The stimulation pulse train parameters includes at least a pulse amplitude and pulse duration for stipulation pulses of the stimulation pulse train and an interpulse interval between successive pulses of the stimulation pulse train defining a pulse frequency. The pulse train generator further comprises a visual output display carried by the housing to provide visual output data including at least the stimulation pulse train parameters for each of the stimulation pulse train output channels, a non-volatile memory carried by the housing to store the stimulation pulse train parameters for each of the plurality of stimulation pulse train output channels, a reference and a pulse train regulation system carried by the housing to regulate the stimulation pulse train in accordance with the select pulse train parameters on each of the plurality of stimulation pulse train output channels so that stimulus pulses of the pulse train having the select stimulation pulse train parameters pass between the intramuscular electrodes respectively connected to the pulse train output channels and a reference electrode and a switch carried by the housing for instantaneously generating a stimulus pulse train signal on one of the plurality of output channels in accordance with selected stimulus pulse train parameters when the switch is activated. The system can be used for therapeutic electrical stimulation of select muscles of an individual.
Patent NZ-501842-A (NZ)
Title: Preparing modified anti-IgE antibodies not exhibiting aspartyl isomerisation deactivation
Inventor: LOWMAN HENRY B
IPC: A61K38/00
Filed: 1998-06-30
Abstract: A method for producing anti-IgE antibodies which do not exhibit aspartyl isomerisation deactivation and which have an affinity for IgE comprises: 1) identifying aspartyl residues which are prone to isomerization; 2) substituting alternative naturally occurring amino acid residues and screening the resulting mutants for affinity against the target molecule, by affinity maturation using phage display, which process comprises; i) substitution, deletion or insertion of one or more codons in the gene encoding the polypeptide which results in a change in the amino acid sequence of the polypeptide, such as to prepare a library of structurally  related polypeptides fused to a phage coat protein; ii) displaying  a single copy of each related polypeptide on the surface of the phagemid particle containing DNA encoding that polypeptide, and; 3) selecting modified polypeptides in which an aspartyl residue has been changed and which have an affinity for the target molecule which is equal to or greater than the unmodified polypeptide.
Patent NZ-504725-A (NZ)
Title: Flavivirus expression and delivery system
Inventor: WESTAWAY EDWIN G
IPC: C12N15/86
Filed: 1998-11-30
Abstract: A gene expression system comprising: a) a self-replicating expression vector of flavivirus origin which includes the flavivirus 5' untranslated region (UTR), at least a portion of the 5' coding region for flavivirus core protein, the nucleotide sequence coding for the flavivirus non-structural proteins, and the complete or most of the 3'-terminal sequence of the flavivirus 3'UTR, required for self-replication of flavivirus genomic material, which vector is adapted to receive at least a nucleotide sequence without disrupting its replication capabilities; and b) at least a second vector that is capable of expressing flavivirus structural protein(s) and any other proteins required for packaging of the self-replicating expression vector into flavivirus viral particles which vector is engineered to prevent recombination with the self-replicating vector when in its presence.
Patent NZ-508110-A (NZ)
Title: Attenuated mutants of salmonella which constitutively express the Vi antigen
Inventor: NORIEGA FERNANDO R
IPC: A61K48/00
Filed: 1999-04-30
Abstract: Attenuated Salmonella mutants that constitutively express the Vi antigen are disclosed, as well as vaccines against typhoid fever, live vector vaccines and DNA-mediated vaccines containing the same.
Patent NZ-512058-A (NZ)
Title: Improvements in road barriers
Inventor: DALRYMPLE GEOFFREY
IPC: E01F15/08
Filed: 1999-10-14
Abstract: A road barrier (10) comprises an elongate container configured to receive and hold a volume of water. The barrier (10) is made from a plastics material and has a base (12), end walls (18a,18b), each of the end walls having means for releasably coupling the barrier in end to end relation with a like barrier, side walls (14a, 14b), and a top (16).  The barrier (10) includes a water fill hole in its top to enable the barrier to be filled with water and a discharge hole near its base for enabling water to be discharged from the barrier. The side walls (14a, 14b) of the barrier (10) define a lower face (52) which is inclined and extends outwardly away from a central longitudinal axis (A-A) of the barrier, a step portion (54) which extends inwards towards the central longitudinal axis of the barrier and an upper inclined face (62) which extends away from the central longitudinal axis of the barrier.  This contouring of the side wall helps to prevent vehicle tyres from riding up the sides of the barrier. The road barrier includes a plurality of mounting means, located at each side of both ends of the barrier adjacent the ends of the barrier, at the base of the barrier and also at the top of the barrier adjacent the upper inclined faces. The mounting means are used for mounting latch plates to the barrier to enable one barrier to be connected on both sides top and bottom to the mounting means of another opposed barrier in end to end relation. The barrier also includes a visible float (36) to indicate whether the barrier is full of water or not.
Patent NZ-517554-A (NZ)
Title: Oral pharmaceutical forms of administration of tramadol with a delayed action
Inventor: ZIEGLER IRIS
IPC: A61K47/12
Filed: 2000-08-03
Abstract: An at least partially sustained-release, oral pharmaceutical administration form of tramdol wherein the sustained-release portion of the pharmaceutical active substance is present as a compound with a water solubility of </= 100mg/ml formed in situ from tramadol and another acidic pharmaceutical active substance and/or auxiliary substance is described. Preferably the other active substance is selectd from diclofenac sodium, naproxen, acetylsalicyclic acid, salicyclic acid, bezoic acid, saccharin, cyclamate or acesulfame. The administration form can be used for the control of pain and the treatment of urinary incontinence. As described is a process for the preparation of the administration form.
Patent NZ-518252-A (NZ)
Title: Solid sustained-release drug formulations for implantation comprising carbonate
Inventor: SANO AKIHIKO
IPC: A61K47/02
Filed: 2000-10-31
Abstract: A solid formulation for implantation, which comprises one of particle combinations, which is selected from a group consisting of (a), (b) and (c), as well as a carrier comprising a hydrophobic polymer, wherein the particle combination is dispersed into the carrier. (a) is a particle combination which comprises particles comprising an active ingredient, particles comprising a carbonate, and particles comprising a substance which is reacted with the carbonate in an aqueous solution to generate carbon dioxide; (b) is a particle combination which comprises particles comprising an active ingredient and a carbonate, and particles comprising a substance which is reacted with the carbonate in an aqueous solution to generate carbon dioxide; (c) is a particle combination which comprises particles comprising a carbonate, and particles comprising an active ingredient and a substance which is reacted with the carbonate in an aqueous solution to generate carbon dioxide.
Patent NZ-521311-A (NZ)
Title: Disinfecting wooden elements in contact with foodstuff
Inventor: BLONDEAU ERIC
IPC: A61L2/12
Filed: 2001-03-08
Abstract: The method involves subjecting the barrel to a magnetic field with a frequency of between one megahertz and three hundred gigahertz to destroy at least part of the colony of microorganisms. The frequency can be between eight hundred and sixty five and five thousand eight hundred and fifty megahertz. The barrel can be moved with respect to the field source to provide a uniform treatment. Claims include an installation for disinfection using the method
Patent NZ-524425-A (NZ)
Title: Orifice cup for manually actuated sprayer
Inventor: DOBBS DOUGLAS B
IPC: B05B1/34
Filed: 2003-02-26
Abstract: A manually actuated sprayer comprising, a body member having a discharge passage terminating in a discharge orifice through which liquid product issues on sprayer actuation, an orifice cup mounted within the discharge passage, the orifice cup comprising a base wall with an integral skirt extending in an upstream direction relative to passage of the liquid product, said discharge passage includes a cylindrical bore of a predetermined wall diameter, the base wall of the orifice cup containing the discharge orifice and the base wall having an outer diameter substantially the same as said predetermined wall diameter, an outer wall of the skirt being frusto-conical and tapering outwardly in the upstream direction such that the maximum diameter of the outer wall exceeds said predetermined diameter, the outer wall of the skirt sealingly engaging the wall of the cylindrical bore for positively retaining the orifice cup within the bore and preventing any passage of the liquid product between the outer wall of the skirt and the wall of the cylindrical bore.
Patent NZ-524953-A (NZ)
Title: Animal tag applicator
Inventor: EADIE BRIAN
IPC: A01K11/00
Filed: 2001-09-21
Abstract: An animal tag application apparatus is provided which comprises a body (1) and a pivoting lever (2). The lever has attached thereto a push rod (3) and actuating member (4) which act as the operating means for both the applicator jaws which apply the tag (8) to the animal and a tag delivery means which pushes subsequent tags into the jaws. The delivery means comprises a toothed gear wheel (11) that is acted upon by ratchet mechanism to rotate the wheel and hence push the tags into the applicator jaws. A guide may also be provided to ensure smooth movement of the tags under the action of the delivery means. Thus, the operating means of the apparatus operates both the application of the tag and the delivery of the subsequent tag from a single operation of the lever.
Patent NZ-525901-A (NZ)
Title: Global electronic trading system
Inventor: GLODJO ARMAN
IPC: G06Q40/00
Filed: 2001-11-08
Abstract: This system facilitates trading two items (L, Q) from the group of items comprising commodities and financial instruments. There are at least two agents (2) wanting to trade the items (L, Q) and a trading channel (3) between each pair of agents (2) allowing for the execution of trades. There are flow limits on the traded items and on any underlying instruments to be exchanged upon settlement of the traded items. A central computer (1) is coupled to the at least two agents (2). The computer (1) is adapted to convey to each agent (2) individualised current tradable bid and offered prices and sizes subject to the agent's (2) flow limits
Patent NZ-526470-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: BEBBINGTON DAVID
IPC: A61K31/513
Filed: 2001-12-19
Abstract: Disclosed are compounds of formula IIIa, wherein: Rx and Ry are independently T-R3 or L-Z-R3, R1 is T-(Ring D) R2 and R2Æ independently are -R, -T-W-R6 or taken together R2 and R2Æ are a 5-8 membered ring optionally containing heteroatoms, Ring D is a 5-7 membered mono- or bicyclic ring optionally containing heteroatoms, T is a bond or an alkylidene chain, Z is an alkylidene chain. The compounds are used in the manufacture of medicaments for inhibiting Aurora-2, GSK-3, or Src activity.
Patent NZ-529063-A (NZ)
Title: Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Inventor: ALITALO KARI
IPC: A61K47/48
Filed: 1999-10-08
Abstract: Describes the use of a first compound that specifically binds a mammalian Flt4 receptor tyrosine kinase (Flt4) in the manufacture of a medicament for detecting neovascular endothelial cells in a mammal. (62) Divided out of 511408
Patent NZ-538284-A (NZ)
Title: Use of urease and targeting molecule for inhibiting cancer cell growth
Inventor: SEGAL DONALD
IPC: A61K47/48
Filed: 2003-07-16
Abstract: A pharmaceutical composition for the use in inhibiting growth of cancer cells in a mammalian subject comprises: a urease enzyme; and a chemical entity conjugated to the urease enzyme and selected from the group consisting of an anti-tumor antigen antibody, anti-hCG antibody, and a ligand capable of binding specifically to cancer cell surface receptors and being effective to enhance the delivery of the enzyme to cancer cells, when the composition is administered to a subject; and a pharmaceutical carrier. Also described is a gene therapy composition for the use in inhibiting growth of cancer cells in a mammalian subject, comprising a targeting vector effective, when administered to the subject, of selectively transfecting cancer cells, and carried within the vector is a recombinant nucleic acid sequence effective to produce a urease mRNA in transfected cancer cells.
Patent NZ-541889-A (NZ)
Title: System and method for measuring cross-sectional areas and pressure gradients in luminal organs
Inventor: KASSAB GHASSAN
IPC: A61B5/296
Filed: 2004-02-18
Abstract: To calculate the cross-sectional area of a treatment site so as to be able to choose a suitably sized stent for insertion into the treatment site, the conductivities of two respective compounds of different conductivities and the conductance values that are recorded during a procedure involving sequential injection of the two compounds to the treatment site are entered into a suitably programmed microprocessor which uses this input data to calculate the cross-sectional area of the treatment site.
Patent NZ-544449-A (NZ)
Title: Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
Inventor: ZABLOCKI JEFF
IPC: A61P9/06
Filed: 2004-06-07
Abstract: Disclosed is a compound of formula I, wherein R9 is optionally substituted aryl or benzyl, R11 is optionally substituted benzothiazolyl, X is N and Y is alkylene of 1-3 carbon atoms, and the remaining substituents are as defined in the specification. The compounds are useful for the treatment cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction.
Patent NZ-545762-A (NZ)
Title: Electronic location monitoring system
Inventor: BLAKEWAY DOUGLAS H
IPC: G08B21/22
Filed: 2004-08-20
Abstract: Methods and apparatus (10) for operating a monitoring unit operable to receive signals from a mobile transmitter (12) in an electronic location monitoring system are disclosed. The method involves causing a first receiver to change a signal reception threshold for receiving signals from the mobile transmitter, in response to proximity of the monitoring unit relative to a reference position, where the receiver rejects signals received from the mobile transmitter that have a signal strength below the signal reception threshold and receives and processes signals received from the mobile transmitter that have a signal strength above the signal reception threshold. Alternatively, detection of a first monitoring unit in proximity to a second monitoring unit may cause the second monitoring unit to take over receiving signals from the mobile transmitter while the first monitoring unit is put into a low power mode.